CHAPTER 1. Industry Overview of Intravenous Immunoglobulin Market
1.1. Definition and Scope
1.1.1. Definition of Intravenous Immunoglobulin
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Intravenous Immunoglobulin Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Intravenous Immunoglobulin Market By Product
1.2.3. Intravenous Immunoglobulin Market By Application
1.2.4. Intravenous Immunoglobulin Market By Distribution Channel
1.2.5. Intravenous Immunoglobulin Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Intravenous Immunoglobulin Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Intravenous Immunoglobulin Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Intravenous Immunoglobulin Market By Product
4.1. Introduction
4.2. Intravenous Immunoglobulin Market Revenue By Product
4.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Product, 2020-2032
4.2.2. IGG
4.2.2.1. IGG Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. IGA
4.2.3.1. IGA Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. IGM
4.2.4.1. IGM Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.5. IGD
4.2.5.1. IGD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.6. IGE
4.2.6.1. IGE Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Intravenous Immunoglobulin Market By Application
5.1. Introduction
5.2. Intravenous Immunoglobulin Market Revenue By Application
5.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Application, 2020-2032
5.2.2. Immunodeficiency Diseases
5.2.2.1. Immunodeficiency Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Chronic Inflammatory Demyelinating Polyneuropathy
5.2.3.1. Chronic Inflammatory Demyelinating Polyneuropathy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Chronic Lymphocytic Leukemia & Myasthenia Gravis
5.2.4.1. Chronic Lymphocytic Leukemia & Myasthenia Gravis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Hypogammaglobulinemia
5.2.5.1. Hypogammaglobulinemia Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Congenital AIDS & Multifocal Motor Neuropathy
5.2.6.1. Congenital AIDS & Multifocal Motor Neuropathy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Kawasaki Disease
5.2.7.1. Kawasaki Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.8. Guillain-Barre Syndrome
5.2.8.1. Guillain-Barre Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.9. Immune thrombocytopenia (ITP)
5.2.9.1. Immune thrombocytopenia (ITP) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.10. Others
5.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Intravenous Immunoglobulin Market By Distribution Channel
6.1. Introduction
6.2. Intravenous Immunoglobulin Market Revenue By Distribution Channel
6.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
6.2.2. Hospital Pharmacy
6.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Specialty Pharmacy
6.2.3.1. Specialty Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Intravenous Immunoglobulin Market By Country
7.1. North America Intravenous Immunoglobulin Market Overview
7.2. U.S.
7.2.1. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
7.2.2. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
7.2.3. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.3. Canada
7.3.1. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
7.3.2. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
7.3.3. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Intravenous Immunoglobulin Market By Country
8.1. Europe Intravenous Immunoglobulin Market Overview
8.2. U.K.
8.2.1. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Germany
8.3.1. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. France
8.4.1. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.4.2. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.4.3. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.5. Spain
8.5.1. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.5.2. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.5.3. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.6.2. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.6.3. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Intravenous Immunoglobulin Market By Country
9.1. Asia Pacific Intravenous Immunoglobulin Market Overview
9.2. China
9.2.1. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Japan
9.3.1. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. India
9.4.1. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.2. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Australia
9.5.1. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.2. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. South Korea
9.6.1. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.7.2. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.7.3. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Intravenous Immunoglobulin Market By Country
10.1. Latin America Intravenous Immunoglobulin Market Overview
10.2. Brazil
10.2.1. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Mexico
10.3.1. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Intravenous Immunoglobulin Market By Country
11.1. Middle East & Africa Intravenous Immunoglobulin Market Overview
11.2. GCC
11.2.1. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. South Africa
11.3.1. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Intravenous Immunoglobulin Market
12.1. Intravenous Immunoglobulin Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Intravenous Immunoglobulin Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Baxter International, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. Baxter International, Inc. 2022 Intravenous Immunoglobulin Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Bayer AG
13.3. Biotest AG (Tiancheng International Investment Limited)
13.4. CSL Limited (CSL Behring)
13.5. Grifols, S.A.
13.6. Kedrion S.p.A
13.7. LFB S.A.
13.8. Octapharma AG
13.9. Takeda Pharmaceutical Company Limited
The size of intravenous immunoglobulin market was USD 11.8 Billion in 2022.
The intravenous immunoglobulin market CAGR during the analysis period of 2023 to 2032 is 7.6%.
The key players operating in the global intravenous immunoglobulin market are including Baxter International, Inc., Bayer AG, Biotest AG (Tiancheng International Investment Limited), CSL Limited (CSL Behring), Grifols, S.A., Kedrion S.p.A, LFB S.A., Octapharma AG, and Takeda Pharmaceutical Company Limited.
North America region held the dominating position in intravenous immunoglobulin industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of intravenous immunoglobulin during the analysis period of 2023 to 2032.
The current trends and dynamics in the intravenous immunoglobulin industry include increasing prevalence of immunodeficiency disorders and autoimmune diseases, growing geriatric population, and technological advancements in IVIG production and delivery methods
The IGG product held the maximum share of the intravenous immunoglobulin industry.?
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date